Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia 40Leukemia, Myeloid, Acute 24Congenital Abnormalities 22Leukemia, Lymphocytic, Chronic, B-Cell 16Breast Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Follicular 14Lymphoma, B-Cell, Marginal Zone 14Lymphoma, Mantle-Cell 12Myelodysplastic Syndromes 11Multiple Myeloma 10Lymphoma, Non-Hodgkin 10Lymphoma, Large B-Cell, Diffuse 10Leukemia, Megakaryoblastic, Acute 10Myeloproliferative Disorders 9Lymphoma 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 9Burkitt Lymphoma 9Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelomonocytic, Acute 8Leukemia, Myeloid, Chronic-Phase 8Waldenstrom Macroglobulinemia 7Sezary Syndrome 7Neoplastic Cells, Circulating 7Mycosis Fungoides 7Melanoma 7Lymphoma, T-Cell, Cutaneous 7Lung Neoplasms 7

Interventions

Carboplatin 49Etoposide 46Cisplatin 42Topotecan 39Irinotecan 21Paclitaxel 20Nivolumab 15pembrolizumab 13Gemcitabine 13atezolizumab 11Ipilimumab 11durvalumab 9Radiotherapy 9Doxorubicin 7Bevacizumab 7rovalpituzumab tesirine 6etoposide phosphate 6amrubicin 6Psychiatric Rehabilitation 6PM 01183 6Docetaxel 6Counseling 6trilaciclib 5Temozolomide 5Sunitinib 5Platinum 5Imatinib Mesylate 5Cyclophosphamide 5Bortezomib 5130-nm albumin-bound paclitaxel 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Small Cell Lung Carcinoma × Flow Cytometry × Clear all
NCT00388089 2010-06-29

Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors

University of California, Davis

Phase 1 Completed
24 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡